A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2016
At a glance
- Drugs Vortioxetine (Primary)
- Indications Panic disorder
- Focus Therapeutic Use
- 22 Jul 2016 Status changed from recruiting to completed.
- 27 May 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 25 Mar 2015 New trial record